Armotraz 1 mg contains anastrozole, an oral medication used primarily in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It belongs to a class of drugs called aromatase inhibitors, which are essential in reducing estrogen levels in the body. Since certain types of breast cancer rely on estrogen to grow, lowering this hormone can slow or stop the cancer’s progression. Armotraz is often prescribed after surgery or in cases where the cancer has spread.

Mechanism of Action

Anastrozole works by blocking the enzyme aromatase, which is responsible for converting androgens into estrogens in the body. After menopause, estrogen is mainly produced through this conversion in fat tissues rather than the ovaries. By inhibiting aromatase, anastrozole significantly reduces estrogen levels, effectively cutting off the hormonal fuel that many breast cancers need to grow and survive.

Uses

Armotraz 1 mg is used in the following situations:

• Treatment of early-stage hormone receptor-positive breast cancer in postmenopausal women

• First-line treatment of advanced or metastatic breast cancer

• Adjuvant therapy following surgery and/or radiation

• Continuation therapy for those who have completed 2 to 3 years of tamoxifen therapy

  Adverse Effects

  Common side effects

  • Hot flashes or night sweats

  • Joint or muscle pain

  • Weakness or fatigue

  • Headache

  • Mild skin rashes

  • Nausea